Melissa Barker‐Haliski

1.9k total citations
52 papers, 1.3k citations indexed

About

Melissa Barker‐Haliski is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Melissa Barker‐Haliski has authored 52 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cellular and Molecular Neuroscience, 35 papers in Psychiatry and Mental health and 14 papers in Molecular Biology. Recurrent topics in Melissa Barker‐Haliski's work include Neuroscience and Neuropharmacology Research (39 papers), Epilepsy research and treatment (35 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Melissa Barker‐Haliski is often cited by papers focused on Neuroscience and Neuropharmacology Research (39 papers), Epilepsy research and treatment (35 papers) and Pharmacological Effects and Toxicity Studies (9 papers). Melissa Barker‐Haliski collaborates with scholars based in United States, Germany and United Kingdom. Melissa Barker‐Haliski's co-authors include H. Steve White, Karen S. Wilcox, E. Jill Dahle, Wolfgang Löscher, Aristea S. Galanopoulou, Fabiola Vanegas, Arne Schousboe, Timothy H. Pruess, Karsten K. Madsen and Michaël Bazelot and has published in prestigious journals such as Neuron, International Journal of Molecular Sciences and Neuroscience.

In The Last Decade

Melissa Barker‐Haliski

50 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melissa Barker‐Haliski United States 18 867 641 358 244 208 52 1.3k
Gaetano Terrone Italy 16 417 0.5× 479 0.7× 363 1.0× 255 1.0× 140 0.7× 43 1.3k
Asheebo Rojas United States 22 560 0.6× 283 0.4× 572 1.6× 153 0.6× 126 0.6× 38 1.4k
Brian D. Klein United States 18 703 0.8× 538 0.8× 498 1.4× 254 1.0× 104 0.5× 26 1.2k
Cameron S. Metcalf United States 19 501 0.6× 364 0.6× 242 0.7× 149 0.6× 60 0.3× 50 852
Sam M. Greenwood United Kingdom 13 530 0.6× 506 0.8× 771 2.2× 196 0.8× 106 0.5× 14 1.9k
Kathrin Töllner Germany 21 656 0.8× 446 0.7× 317 0.9× 229 0.9× 47 0.2× 30 940
Merav Bassan Israel 17 613 0.7× 106 0.2× 594 1.7× 231 0.9× 231 1.1× 32 1.3k
Matthew E. Barton United States 16 529 0.6× 341 0.5× 420 1.2× 170 0.7× 171 0.8× 28 1.0k
Olagide Wagner de Castro Brazil 17 385 0.4× 222 0.3× 290 0.8× 95 0.4× 75 0.4× 49 869
Alessia Salamone Italy 13 336 0.4× 186 0.3× 274 0.8× 87 0.4× 118 0.6× 17 672

Countries citing papers authored by Melissa Barker‐Haliski

Since Specialization
Citations

This map shows the geographic impact of Melissa Barker‐Haliski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Barker‐Haliski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Barker‐Haliski more than expected).

Fields of papers citing papers by Melissa Barker‐Haliski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Barker‐Haliski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Barker‐Haliski. The network helps show where Melissa Barker‐Haliski may publish in the future.

Co-authorship network of co-authors of Melissa Barker‐Haliski

This figure shows the co-authorship network connecting the top 25 collaborators of Melissa Barker‐Haliski. A scholar is included among the top collaborators of Melissa Barker‐Haliski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melissa Barker‐Haliski. Melissa Barker‐Haliski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Qian, et al.. (2025). Acute dose-related effect of antiseizure medications on open field exploration of male rats with established epilepsy. Epilepsy & Behavior. 171. 110583–110583. 1 indexed citations
2.
Barker‐Haliski, Melissa. (2025). Seizing the opportunity to therapeutically address neuronal hyperexcitability in Alzheimer's disease. Journal of Alzheimer s Disease. 103(3). 662–665. 1 indexed citations
3.
Anderson, Lyndsey L., Kristopher M. Kahlig, Melissa Barker‐Haliski, et al.. (2025). PAC ‐ FOS: A novel translational concordance framework identifies preclinical seizure models with highest predictive validity for clinical focal onset seizures. Epilepsia. 66(12). 4983–4995.
4.
Smukowski, Samuel N., Cassidy Danyko, Nadia Postupna, et al.. (2024). mRNA and circRNA mislocalization to synapses are key features of Alzheimer’s disease. PLoS Genetics. 20(7). e1011359–e1011359. 4 indexed citations
5.
6.
Barker‐Haliski, Melissa, et al.. (2024). Gut Instincts: Unusual Suspects in Seizure Worsening. Epiliepsy currents. 25(2). 128–130. 1 indexed citations
7.
Barker‐Haliski, Melissa, Ana Beatriz DePaula-Silva, Julika Pitsch, et al.. (2024). Brain on Fire: How Brain Infection and Neuroinflammation Drive Worldwide Epilepsy Burden. Epiliepsy currents. 1076556414–1076556414. 3 indexed citations
8.
Barker‐Haliski, Melissa, et al.. (2023). Loss of normal Alzheimer's disease-associated Presenilin 2 function alters antiseizure medicine potency and tolerability in the 6-Hz focal seizure model. Frontiers in Neurology. 14. 1223472–1223472. 4 indexed citations
9.
Barker‐Haliski, Melissa, Najat Aourz, Guy Nagels, et al.. (2022). Higher susceptibility to 6 Hz corneal kindling and lower responsiveness to antiseizure drugs in mouse models of Alzheimer's disease. Epilepsia. 63(10). 2703–2715. 17 indexed citations
10.
Barker‐Haliski, Melissa, et al.. (2022). Can Old Animals Reveal New Targets? The Aging and Degenerating Brain as a New Precision Medicine Opportunity for Epilepsy. Frontiers in Neurology. 13. 833624–833624. 11 indexed citations
11.
Barker‐Haliski, Melissa, Toshiya Nishi, & H. Steve White. (2022). Soticlestat, a novel cholesterol 24-hydroxylase inhibitor, modifies acute seizure burden and chronic epilepsy-related behavioral deficits following Theiler's virus infection in mice. Neuropharmacology. 222. 109310–109310. 10 indexed citations
12.
13.
Barker‐Haliski, Melissa, et al.. (2021). Development of an antiepileptogenesis drug screening platform: Effects of everolimus and phenobarbital. Epilepsia. 62(7). 1677–1688. 15 indexed citations
14.
Smith, C., et al.. (2019). Loss of presenilin 2 age-dependently alters susceptibility to acute seizures and kindling acquisition. Neurobiology of Disease. 136. 104719–104719. 20 indexed citations
15.
Meeker, Stacey, et al.. (2019). Repeated Intraperitoneal Administration of Low-Concentration Methylcellulose Leads to Systemic Histologic Lesions Without Loss of Preclinical Phenotype. Journal of Pharmacology and Experimental Therapeutics. 371(1). 25–35. 11 indexed citations
16.
Patra, Pabitra Hriday, Melissa Barker‐Haliski, H. Steve White, et al.. (2018). Cannabidiol reduces seizures and associated behavioral comorbidities in a range of animal seizure and epilepsy models. Epilepsia. 60(2). 303–314. 115 indexed citations
17.
Barker‐Haliski, Melissa, Graeme J. Sills, & H. Steve White. (2014). What Are the Arguments For and Against Rational Therapy for Epilepsy?. Advances in experimental medicine and biology. 813. 295–308. 31 indexed citations
18.
Schousboe, Arne, Karsten K. Madsen, Melissa Barker‐Haliski, & H. Steve White. (2014). The GABA Synapse as a Target for Antiepileptic Drugs: A Historical Overview Focused on GABA Transporters. Neurochemical Research. 39(10). 1980–1987. 54 indexed citations
19.
Barker‐Haliski, Melissa, Elissa D. Pastuzyn, & Kristen A. Keefe. (2012). Expression of the core exon-junction complex factor eukaryotic initiation factor 4A3 is increased during spatial exploration and striatally-mediated learning. Neuroscience. 226. 51–61. 16 indexed citations
20.
Nadanaciva, Sashi, John H. Willis, Melissa Barker‐Haliski, et al.. (2009). Lateral-flow immunoassay for detecting drug-induced inhibition of mitochondrial DNA replication and mtDNA-encoded protein synthesis. Journal of Immunological Methods. 343(1). 1–12. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gaetano Terrone Breakdown of academic impact, for papers by Asheebo Rojas Breakdown of academic impact, for papers by Brian D. Klein Breakdown of academic impact, for papers by Cameron S. Metcalf Breakdown of academic impact, for papers by Sam M. Greenwood Breakdown of academic impact, for papers by Kathrin Töllner Breakdown of academic impact, for papers by Merav Bassan Breakdown of academic impact, for papers by Matthew E. Barton Breakdown of academic impact, for papers by Olagide Wagner de Castro Breakdown of academic impact, for papers by Alessia Salamone
Rankless by CCL
2026